Seroprevalence of Herpes simplex Virus Type 2 among Pregnant Women in Sokoto, Sokoto State, Nigeria
DOI:
https://doi.org/10.47430/ujmr.25103.043Keywords:
herpes simplex virus type 2, elisa, pregnant woman, seroprevalanceAbstract
Study’s Excerpt:
- HSV-2 seroprevalence among pregnant women in Sokoto was 6.59%.
- ELISA testing confirmed HSV-2 IgG/IgM antibodies in all age groups.
- Highest prevalence was among women aged 21–30 years (9.1%).
- Urban residents and those with higher education had higher HSV-2 rates.
- Seropositivity was linked to tribe, religion, STIs, and genital ulcer history.
Full Abstract:
Herpes simplex virus type 2 (HSV-2) infections are one of the most common sexually transmitted infections among pregnant women worldwide. This study aimed to assess the seroprevalence of herpes simplex virus type-2 among pregnant women attending antenatal care at Maryam Abacha Women and Children's Hospital, Sokoto, Nigeria. A total of 200 blood samples were screened for HSV-2 among pregnant women. Socioeconomic factors were obtained from a questionnaire, and IgG/IgM antibodies were determined using an ELISA test kit. The Results have shown a prevalence of 6.59% among pregnant women. There was an association between tribe, religion, sexually transmitted Infection symptoms (STIs), history of genital ulcer, and the prevalence of herpes simplex virus type-2 IgM/IgG antibody. Based on age, all four groups were reactive, with the highest prevalence occurring in the age groups 21-30 years (9.1%), ≤ 20 years (6.1%),≥ 40 years (5.6%), and 31-40 years (2.3%). Based on residence, urban settlers have a higher percentage (7.6%) than rural settlers (4.8%). Those with tertiary education (8.7%) have the highest percentage, followed by those with secondary education (8.2%). These findings make it necessary for all expectant mothers to have a serological test for HSV antibodies to detect early and treat congenital Infections as soon as possible.
Downloads
References
Aaron, F. B., Madhivanan, P., Niranjankumar, B., Ravi, K., Arun, A., Krupp, K., & Klausner, J. D. (2013). The epidemiology of herpes simplex virus type-2 infection among pregnant women in rural Mysore Taluk, India. Journal of Sexually Transmitted Diseases, 2013, Article 750415. https://doi.org/10.1155/2013/750415
Amoo, F. K., Muhammad, S. N., Gumel, A. M., Eze, L. C., Baita, N., Mukhtar, S. I., & Sani, D. H. (2020). Seroprevalence of herpes simplex virus type 2 and HIV co-infection among pregnant women in Jigawa State. International Journal of Microbiology and Biotechnology, 5(1), 1–6. https://doi.org/10.11648/j.ijmb.20200501.11
Anaedobe, C. G., & Ajani, T. A. (2019). Co-infection of herpes simplex virus type-2 and HIV infections among pregnant women in Ibadan, Nigeria. Global Infectious Disease, 11(1), 19–24. https://doi.org/10.4103/jgid.jgid_56_18
Apurba, S. S., Sandhya, B. K., Senthamarai, S., Sivasankarai, S., Kumudavathi, M. S., Anitha, C., & Amshavathani, S. K. (2013). Serological evaluation of herpes simplex virus type 1/type 2 infections in pregnant women with bad obstetric history in a tertiary care hospital, Kanchipuram. International Journal of Advance Research, 1, 123–128.
Bochner, A. F., Madhivanan, P., Niranjankumar, B., Ravi, K., Arun, A., Krupp, K., & Klausner, J. D. (2013). The epidemiology of herpes simplex virus type-2 infection among pregnant women in rural Mysore Taluk, India. Journal of Sexually Transmitted Diseases, 2013, 750415. https://doi.org/10.1155/2013/750415
Bujko, M., Sulovic, V., Zivanovic, V., Dotlic, R., & Bardic, I. (2004). Herpes simplex virus (HSV) infection in women with previous spontaneous abortion. Journal of Perinatal Medicine, 16(3), 193–196. https://doi.org/10.1515/jpme.1988.16.3.193
Chawla, R., Bhalla, P., Singh, M. M., & Garg, S. (2008). Community-based study on seroprevalence of herpes simplex virus type 2 infection in New Delhi. Indian Journal of Medical Microbiology, 26(1), 34–39. https://doi.org/10.4103/0255-0857.38855
Chayavichitsilp, P., Buckwalter, J. V., Krakowski, A. C., & Friedlander, S. F. (2009). Herpes simplex. Pediatrics in Review, 30(4), 119–130. https://doi.org/10.1542/pir.30.4.119
Cheesbrough, M. (2006). District laboratory practice in tropical countries, Part 2. Cambridge University Press.
Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., & Hillier, S. L. (2003). Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clinical Infectious Diseases, 30(10), 797–800. https://doi.org/10.1086/375819
Cowan, F. M. (2000). Testing for type-specific antibody to herpes simplex virus—implications for clinical practice. Journal of Antimicrobial Chemotherapy, 45(Suppl. 4), 9–13. https://doi.org/10.1093/jac/45.suppl_4.9
Cusini, M., & Ghislanzoni, M. (2001). The importance of diagnosing genital herpes. Journal of Antimicrobial Chemotherapy, 47(1), 9–16. https://doi.org/10.1093/jac/47.suppl_1.9
Dickerson, F. B., Boronow, J. J., Stallings, C., Origoni, A. E., Cole, S., Krivogorsky, B., & Yolken, R. H. (2004). Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biological Psychiatry, 55(6), 588–593. https://doi.org/10.1016/j.biopsych.2003.10.008
Fischer, T. K., Viboud, C., & Parashar, U. (2007). Hospitalizations and deaths from diarrhea and rotavirus among children younger than 5 years of age in the United States. Journal of Infectious Diseases, 195(8), 1117–1125. https://doi.org/10.1086/512863
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997). Herpes simplex virus type 2 in the United States, 1976 to 1994. New England Journal of Medicine, 337(16), 1105–1111. https://doi.org/10.1056/NEJM199710163371601
Hussan, B. M. (2013). Study the prevalence of ACL, APL, CMV, HSV, Rubella and Toxoplasma gondii in aborted women in Baghdad. Medical Journal of Babylon, 10(2), 455–464.
Kalu, E., Ojide, C. K., Chuku, A., Chukwunoye, I. I., Agwu, F. E., Nwadike, V. U., Korie, F. C., & Okafor, G. O. C. (2015). Obstetric outcomes of human herpes virus-2 infection among pregnant women in Benin, Nigeria. Nigerian Journal of Clinical Practice, 18(4), 453–461. https://doi.org/10.4103/1119-3077.154210
Lema, S. Y., Suleiman, J., Rabiatu, M. S., Aisha, U., & Yakubu, M. S. (2019). Prevalence of Trichomonas vaginalis among pregnant women attending antenatal care (ANC) at Maryam Abacha Women and Children Hospital, Sokoto, Nigeria. European Journal of Pharmaceutical and Medical Research, 6(3), 52–56.
Maitra, N., & Gupta, M. (2007). Seroprevalence and correlates of herpes simplex virus type-2 infection in a general gynecology clinic. Archives of Gynecology and Obstetrics, 275(1), 19–23. https://doi.org/10.1007/s00404-006-0207-2
Mihret, W., Rinke de Wit, T. F., Petros, B., Mekonnen, Y., Tsegaye, A., Wolday, D., Beyene, A., Aklilu, M., Sanders, E., & Fontanet, A. L. (2002). Herpes simplex virus type 2 seropositivity among urban adults in Africa: Results from two cross-sectional surveys in Addis Ababa, Ethiopia. Sexually Transmitted Diseases, 29(3), 175–181. https://doi.org/10.1097/00007435-200203000-00008
Muhammad, I. A., Hafiz, T. R., Muhammad, F., & Rogo, L. D. (2021). Seroprevalence and risk factors of herpes simplex virus type-2 (HSV-2) infection among HIV-positive patients in a selected teaching hospital in Northern Nigeria. OIRT Journal of Medical and Health Sciences, 1(2), 51–55.
Narouz, N., Allan, P. S., Wade, A. H., & Wagstaffe, S. (2003). Genital herpes serotyping: A study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK. Sexually Transmitted Infections, 79(1), 35–41. https://doi.org/10.1136/sti.79.1.35
National Population Commission (NPC). (2007). Report of Nigeria’s National Population Commission on the 2006 Census. Population and Development Review, 33(1), 1–210.
Okonko, I. O., & Cookey, T. I. (2015). Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against herpes simplex virus (HSV) types-1 and -2 in pregnant women in Port Harcourt, Nigeria. African Health Sciences, 15(3), 737–747. https://doi.org/10.4314/ahs.v15i3.6
Okonko, I. O., Awah, A., Omang, P. A., Cookey, T. I., Okonko, B. J., Onu, E. N., Oketah, E. N., Innocent-Adiele, H. C., Adim, C. C., & Amadi, B. O. (2023). Serological evidence of herpes simplex virus type 2 IgM antibody among expectant mothers attending a tertiary health care facility in Port Harcourt, Nigeria. Asian Journal of Research in Nursing and Health, 6, 442–450. https://doi.org/10.4081/mm.2023.10829
Oti, V. B., Usman, B. A., Pennap, G. R., & Eno-Ibanga, C. K. (2017). Seroprevalence of herpes simplex virus type-2 among pregnant women accessing antenatal care in a tertiary healthcare facility in Central Nigeria. Asian Journal of Research in Medical and Pharmaceutical Sciences, 1(4), 1–6. https://doi.org/10.9734/AJRIMPS/2017/37030
Rathore, S., Jamwal, A., & Gupta, V. (2010). Herpes simplex virus type 2: Seroprevalence in antenatal women. Indian Journal of Sexually Transmitted Diseases and AIDS, 31(1), 11–15. https://doi.org/10.4103/0253-7184.68994
Smith, J. S., & Robinson, N. J. (2002). Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. Journal of Infectious Diseases, 186(Suppl. 1), S3–S28. https://doi.org/10.1086/343739
Tideman, R. L., Taylor, J., Marks, C., Seifert, C., Berry, G., Trudinger, B., Cunningham, A., & Mindel, A. (2001). Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sexually Transmitted Infections, 77(6), 413–415. https://doi.org/10.1136/sti.77.6.413
Weiss, H. (2004). Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes, 11(Suppl 1), 24A–35A.
World Health Organization (WHO). (2022). Herpes simplex virus (HSV): Key facts. https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 R S Dangoggo, D N Peni, S B Manga, U K Mohammed, B U Bagudo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
